Ole Vorm has worked with mass spectrometry of proteins since the late 1980’s and received his PhD from the University of Southern Denmark in 1995 after working in the labs of Prof. Peter Roepstorff and Prof. Matthias Mann. After a brief post.doc appointment at the EMBL in Heidelberg, Dr Vorm founded one of the worlds first dedicated proteomics companies, Protana in 1997 and joined MDS Proteomics in 2000 as it acquired Protana. In 2004 Dr. Vorm founded Proxeon that was acquired in 2010 by Thermo Fisher Scientific and from 2014 to 2016 Dr. Vorm served as VP of Proteomics at Bruker Inc. In March 2016, Dr. Vorm founded Evosep, in order to continue to work on ruggedising and simplifying sample handling and separation in connection with mass spectrometry. Dr. Vorm is a firm believer that proteomics will become a cornerstone of precision medicine in the near future and is working to contribute to the necessary technology components.